CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Protein profiling on a rise and technological advancements in polymerase chain reaction
4.1.2. High research and development expenditure by biotechnology companies
4.1.3. Growth in biopharmaceuticals and increase in the number of biotechnology firms
4.1.4. Stem cell research and environmental applications
4.2. Market Restraints & Challenges
4.2.1. The high price of biopharmaceuticals
4.2.2. The growth of non-validated home brew test and reimbursement issues
4.3. Market Opportunities
4.3.1. The rise in the number of diagnostic centers and an increase in awareness and
acceptance of personalized medicine
4.3.2. Reduction in the number of PCR processes
4.3.3. Increase in funding for R&D activities and the presence of untapped markets
CHAPTER 5 GLOBAL POLYMERASE CHAIN REACTION MARKET – BY TECHNOLOGY
5.1. Analytical
5.1.1. Electrophoresis
5.1.2. Chromatography
5.1.3. Flow Cytometry
5.1.4. Mass Spectrometry
5.2. Life Sciences
5.2.1. IVD
5.2.2. Expression & Transfection
5.2.3. PCR
5.2.4. Cell Culture
CHAPTER 6 GLOBAL POLYMERASE CHAIN REACTION MARKET – BY APPLICATION
6.1. DNA & RNA Analysis
6.2. Drug Testing
6.3. Protein Synthesis & Purification
6.4. Gene Expression
CHAPTER 7 GLOBAL POLYMERASE CHAIN REACTION MARKET – BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.2.4. Costa Rica
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Chile
7.3.4. Columbia
7.3.5. Others
7.4. Europe
7.4.1. U.K.
7.4.2. Germany
7.4.3. France
7.4.4. Italy
7.4.5. Spain
7.4.6. Russia
7.4.7. Netherlands
7.4.8. Switzerland
7.4.9. Poland
7.4.10. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. Japan
7.5.3. India
7.5.4. South Korea
7.5.5. Australia & New Zealand
7.5.6. Malaysia
7.5.7. Singapore
7.5.8. Others
7.6. Middle East & Africa
7.6.1. UAE
7.6.2. Saudi Arabia
7.6.3. Iran
7.6.4. Iraq
7.6.5. Qatar
7.6.6. South Africa
7.6.7. Algeria
7.6.8. Morocco
7.6.9. Nigeria
7.6.10. Egypt
7.6.11. Others
CHAPTER 8 GLOBAL POLYMERASE CHAIN REACTION MARKET - COMPANY PROFILES
8.1. Strategic Diagnostics Inc.
8.2. Sysmex Corporation
8.3. Takara Bio Inc.
8.4. Techne Corporation
8.5. Thermo Fisher Scientific Inc.
8.6. Tosoh Corporation
8.7. Waters Corporation
8.8. W.R. Grace & Co.
8.9. Abbott Laboratories, Inc.
8.10. Becton, Dickinson And Company
8.11. Bio-Rad Laboratories Inc.
8.12. Hoefer Inc.
8.13. Life Technologies Corporation
8.14. Meridian Biosciences Inc.
8.15. Promega Corporation
CHAPTER 9 GLOBAL POLYMERASE CHAIN REACTION MARKET – COMPETITIVE LANDSCAPE
9.1. Market Share Analysis
9.2. Strategies adopted by top companies
9.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 10 MARKET INSIGHTS
10.1. Industry Experts Insights
10.2. Analysts Opinions
10.3. Investment Opportunities
CHAPTER 11 APPENDIX
11.1. List of Tables
11.2. List of Figures
